1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25 | On 11/30/23, Licensing Program Analysts (LPAs) Cheyenne Ratajczak and Talwinder Bains arrived at the facility to conduct a Case Management visit regarding an incident that occurred on 10/27/23, 11/07/23 and 11/08/23. LPA met with Administrator Diamond Anderson and explained the reason for the visit.
Alta California Regional Center Special Incident Report (SIR) submitted by facility on 10/28/23 and 11/09/23 to Community Care Licensing (CCL) stated that facility did not give scheduled medications to residents (R1,R2).
1st SIR for 10/28/23- Based on incident report, staff interviews, medication record review and observation from the facility, R1 was supposed to receive, Paliperidone ER 9mg tablet at 2pm on 10/27/23 but staff did not give this medication to R1 as ordered by R1s physician. Facility noticed the medication error on 10/28/23 during audit. Facility notified R1s physician, CCL, ALTA and other agencies regarding this medication error on 10/28/23. Per facility’s reports, there were no changes to R1s health due to this med error and R1 was at their baseline.
2nd SIR for 11/09/23- Based on incident report, staff interviews, medication record review and observation from the facility, R2 was supposed to receive, Nortel 1/35 tablet daily as ordered by R2s physician. Per SIR, R2 did not get this medication on 11/07/23 and 11/08/23 as this medication was not refilled/delivered by pharmacy and facility did not make sure that R2 have their medications refilled/delivered in timely manner. Facility management found out on 11/09/23 that R2 did not have their medications refilled/delivered. Facility did not ensure that R2 have medications refilled/delivered ordered by R2s physician in timely way which resulted R2 missed their medications on 11/07/23 and 11/08/23.
Based on this information, it was determined that the facility did not administer this medication to R1 and R2 which poses a immediate health and safety risk to residents in care. Deficiencies are cited pursuant to California Code of Regulations, Title 22, Section 80075(b)(5)(B) and documented on the attached LIC809D.
The report was reviewed, appeal rights and a copy of this report was left at the facility. |